These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1726940)

  • 1. Human bcr-abl gene has a lethal effect on embryogenesis.
    Heisterkamp N; Jenster G; Kioussis D; Pattengale PK; Groffen J
    Transgenic Res; 1991 Dec; 1(1):45-53. PubMed ID: 1726940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.
    Cobaleda C; Sánchez-García I
    Blood; 2000 Feb; 95(3):731-7. PubMed ID: 10648380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TEC promoter mediates P210(bcr/abl) gene expression in BaF3 cells].
    Zhu YF; Wang YZ; Meng FY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):769-72. PubMed ID: 22739199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted oncogenicity of BCR/ABL p190 in transgenic mice.
    Voncken JW; Griffiths S; Greaves MF; Pattengale PK; Heisterkamp N; Groffen J
    Cancer Res; 1992 Aug; 52(16):4534-9. PubMed ID: 1643646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
    Allen PB; Morgan GJ; Wiedemann LM
    Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.
    MacKenzie E; Stewart E; Birnie GD
    Leukemia; 1993 May; 7(5):702-6. PubMed ID: 8483322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR/ABL induces multiple abnormalities of cytoskeletal function.
    Salgia R; Li JL; Ewaniuk DS; Pear W; Pisick E; Burky SA; Ernst T; Sattler M; Chen LB; Griffin JD
    J Clin Invest; 1997 Jul; 100(1):46-57. PubMed ID: 9202056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study.
    Yin JL; Williams BG; Arthur CK; Ma DD
    Br J Haematol; 1995 Mar; 89(3):539-45. PubMed ID: 7734352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system].
    Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of the bcr/abl oncogene into factor-dependent cells by electroporation: acquisition of autonomous proliferation.
    Takahashi M; Furukawa T; Tanaka I; Ohsawa Y; Nikkuni K; Oaki A; Goto T; Hashimoto T; Kishi K; Koike T
    Hematol Oncol; 1994; 12(2):53-60. PubMed ID: 8070754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.
    Zhang JG; Goldman JM; Cross NC
    Br J Haematol; 1995 May; 90(1):138-46. PubMed ID: 7786776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts.
    Rapozzi V; Xodo LE
    Biochemistry; 2004 Dec; 43(51):16134-41. PubMed ID: 15610007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
    Gharehbaghi K; Burgess GS; Collart FR; Litz-Jackson S; Huberman E; Jayaram HN; Boswell HS
    Leukemia; 1994 Aug; 8(8):1257-63. PubMed ID: 7520100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
    de Fabritiis P; Skorski T; De Propris MS; Paggi MG; Nieborowska-Skorska M; Lisci A; Buffolino S; Campbell K; Geiser T; Calabretta B
    Leukemia; 1997 Jun; 11(6):811-9. PubMed ID: 9177433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.